Connect with us

Health

Cancer vaccine shows promising results for certain patients

Published

on

Cancer vaccine shows promising results for certain patients

There could be new hope on the horizon for kidney cancer patients in the form of an experimental vaccine.

Researchers at Dana-Farber Cancer Institute, Harvard Medical School, Yale Cancer Center and other universities have announced early findings from a study of an anti-tumor vaccine for patients with advanced kidney cancer.

“Patients with stage 3 or 4 kidney cancer are at high risk of recurrence,” said co-senior author and co-principal investigator Toni Choueiri, MD, director of the Lank Center for Genitourinary Cancer at Dana-Farber, in a press release.

Advertisement

DISEASE STARTS ON YOUR PLATE, CARDIOLOGIST SAYS — HERE’S WHAT TO CHANGE

“The tools we have to lower that risk are not perfect, and we are relentlessly looking for more.”

There could be new hope on the horizon for kidney cancer patients in the form of an experimental vaccine. (iStock)

After undergoing surgery to remove a malignant tumor, the study’s nine participants received a cancer vaccine that was intended to “train” their immune systems to identify and attack any lingering cancer cells, according to the press release.

Each vaccine was personalized to match the individual patient’s tumor type based on cancer cells that were removed during surgery. These cells contain “neoantigens,” which are “tiny fragments of mutant proteins,” the release stated. The researchers used “predictive algorithms” to determine which neoantigens should be included in the vaccine to provide the highest level of immunity. 

Advertisement

PROSTATE CANCER CASES SPIKE IN THIS US STATE AS DOCTORS SHARE LIKELY REASON

Five of the patients also received ipilimumab, a type of immunotherapy drug.

All nine patients showed a “successful anti-cancer immune response” after getting the vaccine. After an average of 34.7 months, they all remained cancer-free.

Within three weeks of receiving the vaccine, patients showed an “immune response,” with T-cells spiking by more than 166 times, the release said. (T-cells, also known as T lymphocytes, are immune cells that help to fight cancer and prevent infection.)

“The tools we have to lower that risk are not perfect and we are relentlessly looking for more.”

Advertisement

In the study, the T cells were found to remain in the patient’s body for up to three years and attacked the existing tumor cells.

“We observed a rapid, substantial, and durable expansion of new T cell clones related to the vaccine,” said Patrick Ott, MD, PhD, director of the Center for Cancer Vaccines at Dana-Farber.

“These results support the feasibility of creating a highly immunogenic personalized neoantigen vaccine in a lower mutation burden tumor and are encouraging, though larger-scale studies will be required to fully understand the clinical efficacy of this approach.”

For most stage 3 or 4 kidney cancer patients, the standard treatment is surgical removal of the tumor, which is often followed by an immunotherapy drug. (iStock)

The results of the clinical trial were reported in the journal Nature on Feb. 5. 

Advertisement

“We’re very excited about these results, which show such a positive response in all nine patients with kidney cancer,” Choueiri noted.

For most stage 3 or 4 kidney cancer patients, the standard treatment is surgical removal of the tumor, which is often followed by an immunotherapy drug called Pembrolizumab (Keytruda).

COMMON CANCER TYPE COULD BE DETECTED WITH NEW BLOOD TEST

“Pembrolizumab induces an immune response that reduces the risk of the cancer coming back,” according to Dana-Farber. “However, about two-thirds of patients can still recur and have limited treatment options.”

First author David A. Braun, MD, PhD, a medical oncologist and physician-scientist at Yale Cancer Center and Yale School of Medicine, noted that the approach used in this study was “truly distinct from vaccine attempts in kidney cancer.”

Advertisement

“We pick targets that are unique to the cancer and different from any normal part of the body, so the immune system can be effectively ‘steered’ toward the cancer in a very specific way,” a researcher said in the release.  (iStock)

“We pick targets that are unique to the cancer and different from any normal part of the body, so the immune system can be effectively ‘steered’ toward the cancer in a very specific way,” Braun said in the release. 

“We learned which specific targets in the cancer are most susceptible to immune attack and demonstrated that this approach can generate long-lasting immune responses, directing the immune system to recognize cancer. We believe this work can form a foundation for the development of neoantigen vaccines in kidney cancer.”

‘Exciting and promising’

Charles Nguyen, MD, a medical oncologist who specializes in kidney cancer at City of Hope in Orange County, California, noted that kidney cancer is among the 10 most common cancers among men and women in the U.S. 

“This is a very exciting and promising tool for many of our patients with kidney cancer, where we can one day make a cure possible for all.”

Advertisement

“Patients with early stage (localized) kidney cancer are often first treated with surgery to remove the tumor — however, many patients have a risk of the cancer coming back years after surgery, and there is a great interest in finding ways to lower the risk of cancer recurrence,” Nguyen, who was not involved in the study, told Fox News Digital.

“This exciting clinical trial evaluated a personalized cancer vaccine that uses genetic information from each patient’s cancer to train and enhance the patient’s immune system to recognize the cancer and prevent it from recurring.” 

      

While Nguyen acknowledged that this was a small study, all nine patients who received the vaccine were cancer-free even three years later. 

“This is a very exciting and promising tool for many of our patients with kidney cancer, where we can one day make a cure possible for all.”

Advertisement

Side effects and limitations

Some patients did experience side effects from the vaccine, including local reactions at the vaccine injection site and flu-like symptoms, although “no higher-grade side effects were reported.”

CLICK HERE TO SIGN UP FOR OUR HEALTH NEWSLETTER

The researchers also acknowledged that there were some limitations associated with the study.

“There were limitations in the antigen-prediction tools available at the time and in the ability to target only a single antigen,” they wrote.

Some patients did experience side effects from the vaccine, including local reactions at the vaccine injection site and flu-like symptoms. (IStock)

Advertisement

“Moreover, it was conducted in the setting of active metastatic disease in a number of study participants.”

Future research with larger clinical trials are planned to confirm the vaccine’s effectiveness and full potential, the release stated. 

For more Health articles, visit www.foxnews.com/health

Funding for this study was provided by the Gateway for Cancer Research, the U.S. Department of Defense, Yale Cancer Center, Dana-Farber/Harvard Cancer Center, Harvard Medical School, Trust Family Foundation, Michael Brigham, Pan-Mass Challenge, Hinda L. and Arthur Marcus Foundation, The Loker Pinard Fund for Kidney Cancer Research at Dana-Farber Cancer Institute, National Institutes of Health, Conquer Cancer Foundation/Sontag Foundation, the release stated.

Advertisement

Health

GLP-1s Don’t Work for Everyone: What To Know if You’re Not Seeing Results

Published

on

GLP-1s Don’t Work for Everyone: What To Know if You’re Not Seeing Results


Advertisement





GLP-1 Not Working? Here’s Why and Alternatives That Can Help




















Advertisement





Advertisement


Use left and right arrow keys to navigate between menu items.


Use escape to exit the menu.

Advertisement

Continue Reading

Health

Common eating habit may trigger premature immune system aging, study finds

Published

on

Common eating habit may trigger premature immune system aging, study finds

NEWYou can now listen to Fox News articles!

Eating too much salt has long been linked to high blood pressure, but new research suggests it could trick the immune system into prematurely aging the blood vessels.

A preclinical study recently published in the Journal of the American Heart Association has identified a biological chain reaction that links a salty diet to cardiovascular decay.

Scientists at the University of South Alabama observed that mice on a high-salt diet experienced rapid deterioration in their blood vessel function.

HIGH SALT INTAKE LINKED TO FASTER MEMORY DECLINE IN ONE GROUP, STUDY FINDS

Advertisement

After just four weeks of high sodium intake, the small arteries responsible for regulating blood flow lost their ability to relax, according to a press release.

The team found that the cells lining these vessels had entered a state of cellular senescence, a form of premature cellular aging in which cells stop dividing and release a mix of inflammatory signals that can damage surrounding tissue.

Excess salt has long been linked to high blood pressure, but a new study goes deeper into its effects on the cardiovascular system. (iStock)

The researchers tried to replicate this damage by exposing blood vessel cells directly to salt in a laboratory dish, but the cells showed no harmful effects.

CLICK HERE FOR MORE HEALTH STORIES

Advertisement

This suggests that salt isn’t directly causing damage to the vascular lining but that the real culprit may be the body’s own defense mechanism, the researchers noted.

Excess salt may trigger the immune system to release a molecule called interleukin-16 (IL-16), which acts as a messenger that instructs blood vessel cells to grow old before their time, according to the study.

Excess salt may trigger the immune system to release a molecule called interleukin-16, which acts as a messenger that instructs blood vessel cells to grow old before their time, according to the study. (iStock)

Once these cells age, they fail to produce nitric oxide, the essential gas that tells arteries to dilate and stay flexible.

To test whether this process could be reversed, the team turned to a class of experimental drugs known as senolytics.

Advertisement

CLICK HERE TO DOWNLOAD THE FOX NEWS APP

Using a cancer medication called navitoclax, which selectively clears out aged and dysfunctional cells, the researchers were able to restore nearly normal blood vessel function in the salt-fed mice, the release stated.

TEST YOURSELF WITH OUR LATEST LIFESTYLE QUIZ.

By removing the decaying cells created by the high-salt diet, the drug allowed the remaining healthy tissue to maintain its elasticity and respond correctly to blood flow demands.

Excess salt may trigger the immune system into stopping the cells from dividing, the study suggests. (iStock)

Advertisement

The study did have some limitations. The transition from mouse models to human treatment remains a significant hurdle, the team cautioned.

CLICK HERE TO SIGN UP FOR OUR HEALTH NEWSLETTER

Senolytic drugs like navitoclax are still being studied for safety, and the team emphasized that previous trials have shown mixed results regarding their impact on artery plaque.

Additionally, the researchers have not yet confirmed whether the same IL-16 pathway is the primary driver of vascular aging in humans.

Advertisement
Continue Reading

Health

Healthy diets spark lung cancer risk in non-smokers as pesticides loom

Published

on

Healthy diets spark lung cancer risk in non-smokers as pesticides loom

NEWYou can now listen to Fox News articles!

Eating a diet high in fruits and vegetables was found to have a surprising link to lung cancer among younger non-smokers, early research suggests.

The observational study, led by Jorge Nieva, M.D., of the USC Norris Comprehensive Cancer Center at Keck Medicine, was presented this month at the American Association for Cancer Research (AACR) annual meeting in San Diego. It has not yet been peer-reviewed. 

Researchers looked at dietary, smoking and demographic data for 187 patients who were diagnosed with lung cancer at age 50 or younger. 

PANCREATIC CANCER PATIENT SURVIVAL DOUBLED WITH HIGH DOSE OF COMMON VITAMIN, STUDY FINDS

Advertisement

They found that among non-smokers, there was a link between healthier-than-average diets – rich in fruits, vegetables and whole grains – and the chance of lung cancer development.

Young lung cancer patients ate more servings of dark green vegetables, legumes and whole grains compared to the average U.S. adult, the researchers found.

Eating a diet high in fruits and vegetables was found to have a surprising link to lung cancer among younger non-smokers, early research suggests. (iStock)

The researchers hypothesized that pesticides applied to conventionally grown produce could be a possible factor in the disease association.

“Commercially produced (non-organic) fruits, vegetables and whole grains are more likely to be associated with a higher residue of pesticides than dairy, meat and many processed foods,” according to Nieva. He also noted that agricultural workers exposed to pesticides tend to have higher rates of lung cancer.

Advertisement

HIDDEN VIRUS INSIDE GUT BACTERIA LINKED TO DOUBLED COLORECTAL CANCER RISK, STUDY FINDS

“There is a large subset of lung cancer patients whose disease is not caused by smoking,” Nieva told Fox News Digital.

The disease is becoming more common in non-smokers 50 and younger, especially women – despite the fact that smoking rates have been falling for decades, the researcher noted.

The researchers hypothesized that pesticides applied to conventionally grown produce could be a possible factor in the disease association. (iStock)

“These patients tend to have eaten much healthier diets before their diagnosis than the average American,” he went on. “We need to support research into understanding why Americans – and women in particular – who no longer smoke very much are still having lung cancer,” he said.

Advertisement

DEATHS FROM ONE TYPE OF CANCER ARE SURGING AMONG YOUNGER ADULTS WITHOUT COLLEGE DEGREES

The study did have some limitations, Nieva acknowledged, primarily that it relied on survey data and was limited by the participants’ memories of their food intake.  

“Also, the survey participants were self-selected, and this could have biased the findings,” he told Fox News Digital.

“There is a large subset of lung cancer patients whose disease is not caused by smoking.”

The researchers did not test specific foods for pesticides, relying instead on average pesticide levels for certain types of food. Looking ahead, they plan to test patients’ blood and urine samples to directly measure pesticide levels, Nieva said.

Advertisement

Although the study shows only an association and does not prove that pesticides caused lung cancer, Nieva recommends that people wash their produce before eating and choose organic foods whenever possible.

CLICK HERE FOR MORE HEALTH STORIES

“This work represents a critical step toward identifying modifiable environmental factors that may contribute to lung cancer in young adults,” said Nieva. “Our hope is that these insights can guide both public health recommendations and future investigation into lung cancer prevention.”  

“It is possible that the increased lung cancer risk could be due to pesticide exposure in whole farmed foods, but is by no means certain,” a doctor said. (AP Photo/Charlie Neibergall)

Dr. Marc Siegel, Fox News senior medical analyst, said the study is “interesting,” but that it “raises far more questions than it answers.”

Advertisement

“It is a small study (around 150) and observational, so no proof,” the doctor, who was not involved in the research, told Fox News Digital.

CLICK HERE TO SIGN UP FOR OUR HEALTH NEWSLETTER

“It is possible that the increased lung cancer risk could be due to pesticide exposure in whole farmed foods, but it is by no means certain,” Siegel went on. “How much exposure is needed? How much of it gets into food and in which areas? This requires much further study.”

CLICK HERE TO DOWNLOAD THE FOX NEWS APP

Kayla Nichols, communications director for Pesticide Action & Agroecology Network, a distributed global network, said the organization agrees with the study’s conclusion that more research should be done on the rise in lung cancer, particularly in individuals eating diets higher in produce and fiber.

Advertisement

“There is a large subset of lung cancer patients whose disease is not caused by smoking,” the researcher told Fox News Digital. (iStock)

“There is a bounty of existing research that already links pesticide exposure to increased risk of multiple types of cancers,” Nichols, who was also not involved in the study, told Fox News Digital. She called for more research on chronic, low-level exposures to pesticides, as well as more effective policies to protect the public from pesticide residues on food.

TEST YOURSELF WITH OUR LATEST LIFESTYLE QUIZ

The study was supported by the National Institutes of Health and the National Cancer Institute, as well as industry partners including AstraZeneca and Genentech, among others.

Fox News Digital reached out to several pesticide companies and trade groups for comment.

Advertisement

Continue Reading
Advertisement

Trending